Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Outcomes of Autograft versus Allograft in Pediatric Knee Osteochondral Defects

Autograft (Mosaicplasty) Outcomes

  • The American Academy of Orthopaedic Surgeons recommends autograft transplantation for pediatric patients with small to medium-sized defects, providing excellent clinical outcomes with immediate restoration of hyaline cartilage in a single procedure 1, 4
  • Autografts are indicated for patients under 45 years with focal, full-thickness lesions <3 cm² in size without signs of osteoarthritis, with advantages including elimination of need for second surgical procedure, superior mechanical properties, and immediate or near-immediate weight bearing after surgery 1
  • The main limitation of autografts is donor site morbidity, which can be minimized by careful harvest technique and limiting the number of plugs taken 2, 5

Allograft Outcomes

  • The American Academy of Orthopaedic Surgeons recommends allograft transplantation for larger osteochondral defects in pediatric patients, demonstrating excellent clinical results 2
  • Allografts are indicated for patients ≤50 years with defects >2.5 cm² or with substantial subchondral bone loss, with advantages including elimination of donor site morbidity and provision of immediate mechanically functional joint surface 2, 5
  • However, allografts have limitations, including risk of disease transmission and relative paucity of donor tissue 2, 5

Decision Algorithm for Pediatric Knee Osteochondral Defects

  • For lesions <2 cm², the American Academy of Orthopaedic Surgeons recommends autograft (mosaicplasty) as the first-line treatment, with osteochondral allograft (single plug) or microfracture as second-line options 3
  • For lesions 2-6 cm², osteochondral allograft is recommended as the first-line treatment, with osteochondral autograft (for lesions closer to 2 cm²) as a second-line option 3
  • For lesions >6 cm², osteochondral allograft is preferred due to donor site limitations with autograft 3

Clinical Pearls and Pitfalls

  • Proper patient selection is crucial for success and long-term graft viability, regardless of technique chosen, and fresh allografts should be used within 28 days to maintain chondrocyte viability 2
  • Both autograft and allograft techniques provide hyaline cartilage, which has superior mechanical properties compared to fibrocartilage resulting from microfracture techniques 1, 2

REFERENCES

1

joint-preserving surgical options for management of chondral injuries of the hip. [LINK]

The Journal of the American Academy of Orthopaedic Surgeons, 2014

2

joint-preserving surgical options for management of chondral injuries of the hip. [LINK]

The Journal of the American Academy of Orthopaedic Surgeons, 2014

3

joint-preserving surgical options for management of chondral injuries of the hip. [LINK]

The Journal of the American Academy of Orthopaedic Surgeons, 2014

4

joint-preserving surgical options for management of chondral injuries of the hip. [LINK]

The Journal of the American Academy of Orthopaedic Surgeons, 2014

5

joint-preserving surgical options for management of chondral injuries of the hip. [LINK]

The Journal of the American Academy of Orthopaedic Surgeons, 2014